rs10883100

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_021828.5(HPSE2):​c.1736A>T​(p.Tyr579Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.497 in 1,613,592 control chromosomes in the GnomAD database, including 201,094 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 21512 hom., cov: 32)
Exomes 𝑓: 0.49 ( 179582 hom. )

Consequence

HPSE2
NM_021828.5 missense

Scores

2
1
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 7.54

Publications

32 publications found
Variant links:
Genes affected
HPSE2 (HGNC:18374): (heparanase 2 (inactive)) This gene encodes a heparanase enzyme. The encoded protein is a endoglycosidase that degrades heparin sulfate proteoglycans located on the extracellular matrix and cell surface. This protein may be involved in biological processes involving remodeling of the extracellular matrix including angiogenesis and tumor progression. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
HPSE2 Gene-Disease associations (from GenCC):
  • urofacial syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Ochoa syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.144491E-4).
BP6
Variant 10-98459617-T-A is Benign according to our data. Variant chr10-98459617-T-A is described in ClinVar as [Benign]. Clinvar id is 802626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.61 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HPSE2NM_021828.5 linkc.1736A>T p.Tyr579Phe missense_variant Exon 12 of 12 ENST00000370552.8 NP_068600.4 Q8WWQ2-1Q2M1H9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HPSE2ENST00000370552.8 linkc.1736A>T p.Tyr579Phe missense_variant Exon 12 of 12 1 NM_021828.5 ENSP00000359583.3 Q8WWQ2-1

Frequencies

GnomAD3 genomes
AF:
0.528
AC:
80142
AN:
151876
Hom.:
21498
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.617
Gnomad AMI
AF:
0.485
Gnomad AMR
AF:
0.511
Gnomad ASJ
AF:
0.660
Gnomad EAS
AF:
0.532
Gnomad SAS
AF:
0.453
Gnomad FIN
AF:
0.449
Gnomad MID
AF:
0.494
Gnomad NFE
AF:
0.488
Gnomad OTH
AF:
0.551
GnomAD2 exomes
AF:
0.505
AC:
126889
AN:
251258
AF XY:
0.499
show subpopulations
Gnomad AFR exome
AF:
0.619
Gnomad AMR exome
AF:
0.513
Gnomad ASJ exome
AF:
0.663
Gnomad EAS exome
AF:
0.540
Gnomad FIN exome
AF:
0.462
Gnomad NFE exome
AF:
0.491
Gnomad OTH exome
AF:
0.520
GnomAD4 exome
AF:
0.494
AC:
721963
AN:
1461598
Hom.:
179582
Cov.:
53
AF XY:
0.492
AC XY:
357691
AN XY:
727110
show subpopulations
African (AFR)
AF:
0.628
AC:
21008
AN:
33476
American (AMR)
AF:
0.514
AC:
22990
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.659
AC:
17235
AN:
26134
East Asian (EAS)
AF:
0.565
AC:
22431
AN:
39696
South Asian (SAS)
AF:
0.439
AC:
37900
AN:
86254
European-Finnish (FIN)
AF:
0.475
AC:
25361
AN:
53408
Middle Eastern (MID)
AF:
0.531
AC:
3062
AN:
5766
European-Non Finnish (NFE)
AF:
0.487
AC:
541263
AN:
1111756
Other (OTH)
AF:
0.509
AC:
30713
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
21706
43413
65119
86826
108532
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15986
31972
47958
63944
79930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.528
AC:
80211
AN:
151994
Hom.:
21512
Cov.:
32
AF XY:
0.525
AC XY:
38984
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.617
AC:
25559
AN:
41446
American (AMR)
AF:
0.511
AC:
7809
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.660
AC:
2290
AN:
3470
East Asian (EAS)
AF:
0.531
AC:
2732
AN:
5142
South Asian (SAS)
AF:
0.454
AC:
2183
AN:
4810
European-Finnish (FIN)
AF:
0.449
AC:
4755
AN:
10580
Middle Eastern (MID)
AF:
0.507
AC:
149
AN:
294
European-Non Finnish (NFE)
AF:
0.488
AC:
33139
AN:
67958
Other (OTH)
AF:
0.547
AC:
1154
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1940
3880
5819
7759
9699
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
692
1384
2076
2768
3460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.509
Hom.:
15044
Bravo
AF:
0.542
TwinsUK
AF:
0.484
AC:
1795
ALSPAC
AF:
0.498
AC:
1920
ESP6500AA
AF:
0.621
AC:
2738
ESP6500EA
AF:
0.487
AC:
4185
ExAC
AF:
0.504
AC:
61157
Asia WGS
AF:
0.526
AC:
1831
AN:
3478
EpiCase
AF:
0.492
EpiControl
AF:
0.490

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Urofacial syndrome type 1 Benign:2
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
22
DANN
Benign
0.94
DEOGEN2
Benign
0.19
.;T;.;.
Eigen
Benign
0.18
Eigen_PC
Uncertain
0.30
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.75
T;T;T;T
MetaRNN
Benign
0.00011
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.65
.;N;.;.
PhyloP100
7.5
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-0.63
.;N;N;.
REVEL
Benign
0.15
Sift
Benign
1.0
.;T;T;.
Sift4G
Benign
1.0
T;T;T;T
Polyphen
0.0010, 1.0
.;B;D;D
Vest4
0.24, 0.32, 0.51
MPC
0.15
ClinPred
0.037
T
GERP RS
5.3
Varity_R
0.19
gMVP
0.59
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10883100; hg19: chr10-100219374; COSMIC: COSV65184036; API